News

Trethera Awarded $2.3 Million NIH Grant to Study TRE-515 Combined with Radiation Therapy in Prostate Cancer Preclinical Models

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...
Johns Hopkins Medicine4h

A 19-Year Fight Against Prostate Cancer Brings Man to Johns Hopkins Medicine

Following years of rotating treatments, Pepol and his family moved once more, this time to Virginia, to be close to their now ...
Mirage News5h

19-Year Cancer Battle Leads Man to Johns Hopkins

Dean Pepol is no stranger to prostate cancer.Prostate cancer is the second-leading type of cancer death in American men, and Pepol has experienced ...

Perspective Therapeutics to Participate in Upcoming September Conferences

OPCO Targeted Radiopharmaceutical Therapies in Oncology Summit – Panel Discussions Date: Thursday, September 11, 2025 Location : New York, NY Panel : Challenging Market Leaders Pluvicto & Lutathera ...